Biotechnology

Bayer Schering Pharma extends research portfolio in the field of cancer-related targets

30 Jun 2009

Monsanto and Bayer CropScience cross license herbicide tolerance traits in Canola

30 Jun 2009

Dow and Algenol Biofuels to build pilot-scale algae-based integrated biorefinery

30 Jun 2009

Biocon, Mylan tie up for generic biologic drugs

29 Jun 2009

Genzyme confident of restarting virus-hit Allston plant by August

26 Jun 2009

Biocon’s Q4 profit plummets by 62 per cent

28 Apr 2009

Bristol-Myers, Syngene open new R&D facility

24 Mar 2009

Exact Sciences rebuffs Sequenom's $41 million buyout offer

13 Jan 2009

AstraZeneca, Abraxis rethink cancer drug deal

26 Nov 2008

Tata Chem, Temasek Life Science in jatropha JV

25 Nov 2008

Government to launch Rs350 crore biotechnology partnership programme

06 Nov 2008

Biotech company Osiris ties up with Genzyme in $1.4-billion deal

06 Nov 2008

Gene Logic and deSciner to create Genomics Gateway

10 Oct 2008

Gene therapy may be applied to cure deafness: Nature magazine

29 Aug 2008

Genentech rejects Roche’s $43.7-billion takeover offer as too low

13 Aug 2008

Biotechnology giant Genentech Inc today rejected a $43.7-billion takeover bid from its majority shareholder, Roche Holding AG, as too low, while saying it would be open to a higher proposal.

PerkinElmer appoints its chief scientific officer Daniel Marshak to head China operations

10 Jul 2008

GVK BIO enters into drug discovery pact with Wyeth Pharmaceuticals

26 May 2008

Biocon close to finalising AxiCorp acquisition; establishes cardiology division

22 Apr 2008

Ranbaxy introduces world's first biogeneric injectible drug for osteoporosis

03 Apr 2008

Ranbaxy has introduced the world's first injectible drug for the treatment of osteoporosis using an artificial human hormone

Biocon eyes more acquisitions overseas

27 Feb 2008

Avesthagen Limited launches nutritional botanical bioactive supplements

21 Feb 2008

Biocon to acquire European pharma distributor AxiCorp to enter Europe

11 Feb 2008

Biocon Ltd is acquiring a 70-per cent stake in German specialised pharmaceutical marketer and distributor AxiCorp GmbH for €30 million.

Cerus will spin off its immunotherapy business

24 Nov 2007

Biobase enters into custom curation service agreement with Procter & Gamble

17 Nov 2007

Biocon plans Rs 100 crore annual research spend

By Our Corporate Bureau | 31 Oct 2007